Skip to content

Exploratory research of neointimal formation after stent and optimal duration of dual antiplatelet therapy

Exploratory research of neointima detected by optical coherence tomography after placement of flow diverter for intracranial aneurysm and optimal duration of dual antiplatelet therapy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs032240032
Enrollment
6
Registered
2024-04-16
Start date
2024-05-24
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracranial aneurysm flow diverter, OCT, neointima

Interventions

OCT is performed to evaluate neointima over the stent struts at 1, 3 and 6 months after placement of flow diverter.
OCT, neointima, flow diverter, dual antiplatelet therapy

Sponsors

Matsuda Yoshikazu
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients that placement of flow diverter is scheduled for intracranial aneurysm. 2) Patients that infromed consent was obtained. 3) between 18 and 80 years old.

Exclusion criteria

Exclusion criteria: 1) Patient that antiplatelet therapy and anticoagulant therapy is not available. 2) Patient with allergy for drugs used under procedure. 3) Patient that cerebral angiography is difficult to be performed. 4) Patient that investigator judged inappropriate in this research.

Design outcomes

Primary

MeasureTime frame
Period that All stent struts are covered completely. Safety: all adverse events, medical noncomformity

Secondary

MeasureTime frame
Position that initiatial neointima is covered on stent struts. Eccentricity of neointima covered on stent struts. Period of discontinuation of dual antiplatelet therapy Adhesion ratio between stent strut and vessel wall

Contacts

Public ContactYoshikazu Matsuda

Showa Medical University Hospital

ymatsuda0517@med.showa-u.ac.jp+81-3-3784-8000

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026